These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7511196)

  • 1. Significance of NS3 and NS5 antigens in screening for HCV antibody.
    Goffin E; Pirson Y; Cornu C; Jadoul M; van Ypersele de Strihou C
    Lancet; 1994 Apr; 343(8901):854. PubMed ID: 7511196
    [No Abstract]   [Full Text] [Related]  

  • 2. Significance of NS3 and NS5 antigens in screening for HCV antibody.
    Courouce AM; Bouchardeau F; Girault A; Le Marrec N
    Lancet; 1994 Apr; 343(8901):853-4. PubMed ID: 7511195
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance of NS3 and NS5 antigens in screening for HCV antibody.
    Vernelen K; Claeys H; Verhaert H; Volckaerts A; Vermylen C
    Lancet; 1994 Apr; 343(8901):853. PubMed ID: 7511194
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatitis C antibody and HCV-RNA].
    Yano M
    Nihon Naika Gakkai Zasshi; 1994 Feb; 83(2):192-6. PubMed ID: 7525797
    [No Abstract]   [Full Text] [Related]  

  • 5. Significance of anti-E2 in the diagnosis of HCV infection in patients on maintenance hemodialysis: anti-E2 is frequently detected among anti-HCV antibody-negative patients.
    Lee DS; Lesniewski RR; Sung YC; Min WK; Park SG; Lee KH; Kim HS
    J Am Soc Nephrol; 1996 Nov; 7(11):2409-13. PubMed ID: 8959633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should the c100 antigen be removed from HCV antibody assays?
    Zaaijer HL; Cuypers HT; Reesink HW; Lelie PN
    Vox Sang; 1994; 66(2):150. PubMed ID: 7514326
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays).
    Couroucé AM; Bouchardeau F; Chauveau P; Le Marrec N; Girault A; Zins B; Naret C; Poignet JL
    Nephrol Dial Transplant; 1995; 10(2):234-9. PubMed ID: 7538650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin M antibodies against hepatitis C virus antigens: significance and applications.
    Chen PJ; Hwang LH; Chang LY; Kao JH; Chen DS
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():67-70. PubMed ID: 7689510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical significance of reactivity to individual epitopes of the hepatitis C viral genome.
    Yatsuhashi H; Inokuchi K; Inoue O; Matsumura N; Koga M; Kosakai Y; Yano M
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():6-11. PubMed ID: 7689509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serodiagnosis of hepatitis C by a recombinant hepatitis C virus protein].
    Hayashi N; Yuki N; Kasahara A; Fusamoto H; Kamada T
    Nihon Rinsho; 1993 Feb; 51(2):329-33. PubMed ID: 7681883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serodiagnostic assay of hepatitis C virus infection using viral proteins expressed in Escherichia coli.
    Mori S; Ohkoshi S; Hijikata M; Kato N; Shimotohno K
    Jpn J Cancer Res; 1992 Mar; 83(3):264-8. PubMed ID: 1316340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and its problem for HCV hepatitis].
    Sekiya C
    Hokkaido Igaku Zasshi; 1993 Jul; 68(4):456-60. PubMed ID: 7687972
    [No Abstract]   [Full Text] [Related]  

  • 13. [Progress on diagnosis of hepatitis C].
    Mishiro J
    Nihon Naika Gakkai Zasshi; 1992 May; 81(5):730-6. PubMed ID: 1324966
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis C virus transmission by intravenous immunoglobulin.
    James RC; Mosley JW
    Lancet; 1995 Aug; 346(8971):374; author reply 374-5. PubMed ID: 7542719
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis.
    Czaja AJ; Magrin S; Fabiano C; Fiorentino G; Diquattro O; Craxi A; Pagliaro L
    Dig Dis Sci; 1995 Jan; 40(1):33-40. PubMed ID: 7529673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discovery of the NANB hepatitis virus by gene technology.
    Decker RH
    Beitr Infusionsther; 1992; 30():6-12. PubMed ID: 1284768
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs.
    Pereira BJ; Milford EL; Kirkman RL; Quan S; Sayre KR; Johnson PJ; Wilber JC; Levey AS
    N Engl J Med; 1992 Sep; 327(13):910-5. PubMed ID: 1325035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of specific antibody assay for genotyping of hepatitis C virus.
    Tanaka T; Tsukiyama-Kohara K; Yamaguchi K; Yagi S; Tanaka S; Hasegawa A; Ohta Y; Hattori N; Kohara M
    Hepatology; 1994 Jun; 19(6):1347-53. PubMed ID: 7514558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of oral fluid for hepatitis C antibody screening.
    Sherman KE; Creager RL; O'Brien J; Sargent S; Piacentini S; Thieme T
    Am J Gastroenterol; 1994 Nov; 89(11):2025-7. PubMed ID: 7524312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.